BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 30456697)

  • 1. The Complex Histopathological and Immunohistochemical Spectrum of Neuroendocrine Tumors-An Overview of the Latest Classifications.
    Gheorghișan-Gălățeanu AA; Ilieșiu A; Lambrescu IM; Țăpoi DA
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-Generation Neuroendocrine Immunohistochemical Markers: Reflections from Clinical Implementation.
    Juhlin CC
    Biology (Basel); 2021 Sep; 10(9):. PubMed ID: 34571751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to Manage Small Intestine (Jejunal and Ileal) Neuroendocrine Neoplasms Presenting with Liver Metastases?
    Niederle B; Selberherr A; Niederle MB
    Curr Oncol Rep; 2021 May; 23(7):85. PubMed ID: 34018081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Problems with the diagnosis of metastatic neuroendocrine neoplasms. Which diagnostic criteria should we use to determine tumor origin and help guide therapy?
    Koo J; Dhall D
    Semin Diagn Pathol; 2015 Nov; 32(6):456-68. PubMed ID: 26573790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary hepatic signet ring cell neuroendocrine tumor: a case report with literature review.
    Zhu H; Sun K; Ward SC; Schwartz M; Thung SN; Qin L
    Semin Liver Dis; 2010 Nov; 30(4):422-8. PubMed ID: 20960381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine Liver Metastasis-a Specific Set of Markers to Detect Primary Tumor Sites.
    Selberherr A; Koperek O; Riss P; Scheuba C; Kaderli R; Perren A; Niederle B
    Endocr Pathol; 2019 Mar; 30(1):31-34. PubMed ID: 30456697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDX-1, CDX-2, TTF-1, and CK7: a reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms.
    Chan ES; Alexander J; Swanson PE; Jain D; Yeh MM
    Am J Surg Pathol; 2012 May; 36(5):737-43. PubMed ID: 22498824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of CDX-2 and TTF-1 expressions in separating metastatic neuroendocrine neoplasms of unknown origin.
    Lin X; Saad RS; Luckasevic TM; Silverman JF; Liu Y
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):407-14. PubMed ID: 18091383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CDX2 and Thyroid Transcription Factor-1 in Oropharyngeal Undifferentiated Carcinomas: A Potential Diagnostic Pitfall.
    Chernock RD; Bibbey S; El-Mofty SK; Carpenter DH; Lewis JS
    Appl Immunohistochem Mol Morphol; 2018 Apr; 26(4):268-273. PubMed ID: 27389559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of Islet 1 and PAX8 in identifying metastatic neuroendocrine tumors of pancreatic origin.
    Koo J; Mertens RB; Mirocha JM; Wang HL; Dhall D
    Mod Pathol; 2012 Jun; 25(6):893-901. PubMed ID: 22388755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunohistochemical expression of islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin.
    Koo J; Zhou X; Moschiano E; De Peralta-Venturina M; Mertens RB; Dhall D
    Endocr Pathol; 2013 Dec; 24(4):184-90. PubMed ID: 24037217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NKX2.2, PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumors.
    Yang MX; Coates RF; Ambaye A; Cortright V; Mitchell JM; Buskey AM; Zubarik R; Liu JG; Ades S; Barry MM
    Biomark Res; 2018; 6():15. PubMed ID: 29713473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical Treatment of Small Intestinal Neuroendocrine Tumors G1/G2.
    Selberherr A; Niederle MB; Niederle B
    Visc Med; 2017 Oct; 33(5):340-343. PubMed ID: 29177162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression Pattern of CDX2, Estrogen and Progesterone Receptors in Primary Gastroenteropancreatic Neuroendocrine Tumors and Metastases.
    Zimmermann N; Lazar-Karsten P; Keck T; Billmann F; Schmid S; Brabant G; Thorns C
    Anticancer Res; 2016 Mar; 36(3):921-4. PubMed ID: 26976979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cadherin 17 is frequently expressed by 'sclerosing variant' pancreatic neuroendocrine tumour.
    Johnson A; Wright JP; Zhao Z; Komaya T; Parikh A; Merchant N; Shi C
    Histopathology; 2015 Jan; 66(2):225-33. PubMed ID: 25307987
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.